![Iain Dukes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Iain Dukes
Algemeen Directeur bij
TRAWS PHARMA, INC.
Vermogen: 340 926 $ op 31-05-2026
Profiel
Dr. Iain D. Dukes is Chief Executive Officer bij Viriom, Inc., President & Bestuurder bij Kartos Therapeutics, Inc., Onafhankelijk Bestuurder bij Ikena Oncology, Inc., Venture Partner bij OrbiMed Advisors Private Equity, Voorzitter bij Iovance Biotherapeutics, Inc., Uitvoerend Voorzitter bij Theseus Pharmaceuticals, Inc., President bij Telios Pharmaceuticals, Inc. en President & Chief Executive Officer bij Arrys Therapeutics, Inc. Hij zetelt in de Raad van Bestuur van Angiex, Inc., ENYO Pharma SA, Kartos Therapeutics, Inc., Ikena Oncology, Inc., NeRRe Therapeutics Holdings Ltd., NeRRe Therapeutics Ltd. en ReViral Ltd. Dr. Dukes was voorheen werkzaam als Lid-Raad van Toezicht bij Themis Bioscience GmbH, als SVP & Head-Business Development bij Merck Research Laboratories Massachusetts LLC, als VP-External Research & Development bij Amgen, Inc, een President & Chief Executive Officer bij Essentialis, Inc., een VP-Scientific and Technology Licensing bij GlaxoSmithKline, Inc., een Head-Exploratory Development bij Glaxo Wellcome, Inc., een Principal bij Glaxo, Inc., en een Senior VP-Business Development & Licensing bij Merck & Co. Hij was ook lid van de raad van bestuur van KaNDy Therapeutics Ltd. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Bath, een doctoraatsdiploma aan de Universiteit van Oxford, een doctoraatsdiploma aan de Universiteit van Leeds en een doctoraatsdiploma aan de Universiteit van Oxford.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-06-2026 | 54.000 ( 0,01% ) | 221 400 $ | 31-05-2026 | |
TRAWS PHARMA, INC. 0,54% | 01-05-2026 | 81.867 ( 0,54% ) | 119 526 $ | 31-05-2026 |
Actieve functies van Iain Dukes
| Bedrijven | Functie | Begin |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Voorzitter | 16-08-2016 |
| TRAWS PHARMA, INC. | Algemeen Directeur | 31-03-2025 |
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Oprichter | - |
NeRRe Therapeutics Holdings Ltd.
 NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Directeur/Bestuurslid | 08-09-2017 |
Trawsfynydd Therapeutics, Inc.
 Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing antiviral medicines | Oprichter | 01-01-2021 |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Directeur/Bestuurslid | - |
Lomond Therapeutics, Inc.
 Lomond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company for treating hematological cancers | Algemeen Directeur | - |
Venetian-1 Acquisition Corp.
 Venetian-1 Acquisition Corp. Pharmaceuticals: MajorHealth Technology Develops medicines for hematological malignancies | Algemeen Directeur | 01-11-2024 |
Viriom, Inc.
 Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Algemeen Directeur | 01-02-2019 |
Eerdere bekende functies van Iain Dukes
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Iain Dukes
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
55
Eerstegraads connecties
33
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 33 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Telios Pharmaceuticals, Inc.
Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Health Technology |
Traws Pharma, Inc.
 Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Essentialis, Inc.
 Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Glaxo, Inc. | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
BITOECH Consulting SAS
 BITOECH Consulting SAS Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services Provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity | Distribution Services |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Health Technology |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Ikena Oncology, Inc.
 Ikena Oncology, Inc. BiotechnologyHealth Technology Develops metabolic enzymes based immunotherapy for oncology applications | Health Technology |
Angiex, Inc.
 Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Develops vascular-targeted biotherapeutics designed for the treatment of solid cancers and other diseases of pathological angiogenesis | Commercial Services |
KaNDy Therapeutics Ltd.
 KaNDy Therapeutics Ltd. BiotechnologyHealth Technology Develops medicines for female sex hormone disorders | Health Technology |
Arrys Therapeutics, Inc.
 Arrys Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides treatments to cancer patients | Health Services |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics | Health Technology |
Viriom, Inc.
Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Lomond Therapeutics, Inc.
Lomond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company for treating hematological cancers | Health Technology |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Develops novel small molecules for oncology targets | Health Technology |
Venetian-1 Acquisition Corp.
Venetian-1 Acquisition Corp. Pharmaceuticals: MajorHealth Technology Develops medicines for hematological malignancies | Health Technology |
Trawsfynydd Therapeutics, Inc.
Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing antiviral medicines | Commercial Services |
Eilean Therapeutics LLC
 Eilean Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in discovery and development of small molecule inhibitors therapies for hematological cancers | Health Technology |
